Literature DB >> 11125230

A 13-year study of antimicrobial susceptibility of common gram-negative bacteria isolated from the bloodstream in a teaching hospital.

T K Ling1, E Y Liu, A F Cheng.   

Abstract

The choice of antimicrobial therapy for the treatment of bacteremia is often empirical and based on the knowledge of susceptibility profiles of the most common bacteria. We analyzed blood culture isolates from a teaching hospital for 13 years prospectively. This study examined the susceptibility profiles of 6,616 gram-negative bacteria. Escherichia coli ranked among the commonest bacteria, representing 43.6% (2,890) of all gram-negative isolates. Klebsiella sp. ranked second, 17.7% (1,171) and 16.7% were resistant to ceftazidime in 1997. There was a trend towards an increase in resistance to fluoroquinolones in the common gram-negative bacteria. Imipenem was the most active agent against gram-negative bacteria. The results of the susceptibility of gram-negative bacteria causing bacteremia provide valuable information for implementing the appropriate chemotherapy for bacteremia. Copyright 1999 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11125230     DOI: 10.1159/000048498

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  3 in total

1.  Evaluation of the VITEK 2 system for rapid direct identification and susceptibility testing of gram-negative bacilli from positive blood cultures.

Authors:  Thomas K W Ling; Z K Liu; Augustine F B Cheng
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

2.  An in vitro study on the compatibility and precipitation of a combination of ciprofloxacin and vancomycin in human vitreous.

Authors:  M Hui; A K H Kwok; C P Pang; S W Cheung; R C Y Chan; D S C Lam; A F B Cheng
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

3.  Pharmacokinetics of Intravitreal Vancomycin and Ceftazidime in Silicone Oil-Filled Macaque Eyes.

Authors:  Taku Imamura; Masashi Kakinoki; Daiki Hira; Tomoya Kitagawa; Satoshi Ueshima; Mikio Kakumoto; Tomohiro Terada; Ikuo Kawamoto; Mitsuru Murase; Masahito Ohji
Journal:  Transl Vis Sci Technol       Date:  2021-03-01       Impact factor: 3.283

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.